| Drug Type Small molecule drug | 
| Synonyms ALEVIATIN with PHENOBARBITAL, 複合アレビアチン | 
| Action agonists, blockers | 
| Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists), Nav1.1 blockers(Sodium channel protein type I alpha subunit blockers), Nav1.5 blockers(Sodium channel protein type V alpha subunit blockers) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date Japan (14 Oct 1953),  | 
| Regulation- | 
| Molecular FormulaC15H12N2O2 | 
| InChIKeyCXOFVDLJLONNDW-UHFFFAOYSA-N | 
| CAS Registry57-41-0 | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Seizures | Japan  | 14 Oct 1953 | 





